Lieber Jonathan I's Form 4 filing
Rallybio Corp (RLYB) · filed Feb 23, 2026
- Accession no.
- 0001739410-26-000022
- Filed
- Feb 23, 2026
- Trade date
- Feb 18-23, 2026
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $3.99K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lieber Jonathan ICIK 0001350090 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Common Stock | AGrant or awardAcquired | +2,500 | $0.00 | $0 | 4,904 | Direct | |
| Feb 23, 2026 | Common Stock | SSaleDisposed | −789 | $5.06 | −$3,992.34 | 4,115 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.